Status:
COMPLETED
Telephone Acceptance and Commitment Therapy Intervention for Caregivers of Adults With Dementia
Lead Sponsor:
Indiana University
Collaborating Sponsors:
Indiana Clinical and Translational Sciences Institute
Regenstrief Institute, Inc.
Conditions:
Anxiety
Anxiety Generalized
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Caregivers of adults with dementia report higher distress, including anxiety and depressive symptoms, burden, and existential suffering, than caregivers of people with other chronic diseases. Acceptan...
Detailed Description
The objective of this pilot randomized controlled trial is to assess feasibility, acceptability, and preliminary effects of Telephone Acceptance and Commitment Therapy Intervention for Caregivers (TAC...
Eligibility Criteria
Inclusion
- 21 years or older
- Able to communicate in English
- Able to provide informed consent
- Listed as primary caregiver in the chart of a patient with Alzheimer's disease or a related dementia (ADRD)
- Self-identifies as ADRD patient's primary caregiver
- Intends to continue caregiving for ADRD patient for ≥12 months
- Clinically-elevated anxiety (score of 10 or higher on GAD-7)
Exclusion
- Non-family member of the ADRD patient
- Has ADRD or other serious mental illness diagnosis such as bipolar or schizophrenia as determined by ICD-10 code
Key Trial Info
Start Date :
March 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 9 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04338750
Start Date
March 24 2020
End Date
April 9 2021
Last Update
July 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regenstrief Institute, Inc.
Indianapolis, Indiana, United States, 46202